Idexx Laboratories Stock Probability of Future Stock Price Finishing Under 408.02
| IDXX Stock | USD 491.29 6.50 1.31% |
Closest to current price IDEXX long CALL Option Payoff at Expiration
IDEXX |
IDEXX Laboratories Target Price Odds to finish below 408.02
The tendency of IDEXX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 408.02 or more in 90 days |
| 491.29 | 90 days | 408.02 | near 1 |
Based on a normal probability distribution, the odds of IDEXX Laboratories to drop to $ 408.02 or more in 90 days from now is near 1 (This IDEXX Laboratories probability density function shows the probability of IDEXX Stock to fall within a particular range of prices over 90 days) . Probability of IDEXX Laboratories price to stay between $ 408.02 and its current price of $491.29 at the end of the 90-day period is about 1.31 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.11 . This usually indicates IDEXX Laboratories market returns are sensitive to returns on the market. As the market goes up or down, IDEXX Laboratories is expected to follow. Additionally IDEXX Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. IDEXX Laboratories Price Density |
| Price |
Predictive Modules for IDEXX Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as IDEXX Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of IDEXX Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
IDEXX Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. IDEXX Laboratories is not an exception. The market had few large corrections towards the IDEXX Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold IDEXX Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of IDEXX Laboratories within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.24 | |
β | Beta against NYSE Composite | 1.11 | |
σ | Overall volatility | 22.52 | |
Ir | Information ratio | -0.13 |
IDEXX Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IDEXX Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IDEXX Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| IDEXX Laboratories generated a negative expected return over the last 90 days | |
| IDEXX Laboratories is unlikely to experience financial distress in the next 2 years | |
| The company currently holds 947.88 M in liabilities with Debt to Equity (D/E) ratio of 3.28, implying the company greatly relies on financing operations through barrowing. IDEXX Laboratories has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist IDEXX Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, IDEXX Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IDEXX Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for IDEXX to invest in growth at high rates of return. When we think about IDEXX Laboratories' use of debt, we should always consider it together with cash and equity. | |
| Over 93.0% of IDEXX Laboratories shares are owned by institutional investors | |
| Latest headline from news.google.com: Idexx Laboratories is Now Oversold - Nasdaq |
IDEXX Laboratories Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of IDEXX Stock often depends not only on the future outlook of the current and potential IDEXX Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IDEXX Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 84 M | |
| Cash And Short Term Investments | 453.9 M |
IDEXX Laboratories Technical Analysis
IDEXX Laboratories' future price can be derived by breaking down and analyzing its technical indicators over time. IDEXX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of IDEXX Laboratories. In general, you should focus on analyzing IDEXX Stock price patterns and their correlations with different microeconomic environments and drivers.
IDEXX Laboratories Predictive Forecast Models
IDEXX Laboratories' time-series forecasting models is one of many IDEXX Laboratories' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary IDEXX Laboratories' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about IDEXX Laboratories
Checking the ongoing alerts about IDEXX Laboratories for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for IDEXX Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| IDEXX Laboratories generated a negative expected return over the last 90 days | |
| IDEXX Laboratories is unlikely to experience financial distress in the next 2 years | |
| The company currently holds 947.88 M in liabilities with Debt to Equity (D/E) ratio of 3.28, implying the company greatly relies on financing operations through barrowing. IDEXX Laboratories has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist IDEXX Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, IDEXX Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IDEXX Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for IDEXX to invest in growth at high rates of return. When we think about IDEXX Laboratories' use of debt, we should always consider it together with cash and equity. | |
| Over 93.0% of IDEXX Laboratories shares are owned by institutional investors | |
| Latest headline from news.google.com: Idexx Laboratories is Now Oversold - Nasdaq |
Check out IDEXX Laboratories Backtesting, IDEXX Laboratories Valuation, IDEXX Laboratories Correlation, IDEXX Laboratories Hype Analysis, IDEXX Laboratories Volatility, IDEXX Laboratories History as well as IDEXX Laboratories Performance. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.121 | Earnings Share 10.07 | Revenue Per Share 44.073 | Quarterly Revenue Growth 0.088 | Return On Assets 0.2283 |
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.